Vaxcyte

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Vaxcyte and other ETFs, options, and stocks.

About PCVX

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology.

CEO

Grant E. Pickering

CEOGrant E. Pickering

Employees

254

Employees254

Headquarters

San Carlos, California

HeadquartersSan Carlos, California

Founded

2013

Founded2013

Employees

254

Employees254

PCVX Key Statistics

Market cap

11.02B

Market cap11.02B

Price-Earnings ratio

-18.89

Price-Earnings ratio-18.89

Dividend yield

—

Dividend yield—

Average volume

2.21M

Average volume2.21M

High today

$92.87

High today$92.87

Low today

$85.33

Low today$85.33

Open price

$85.78

Open price$85.78

Volume

1.98M

Volume1.98M

52 Week high

$121.06

52 Week high$121.06

52 Week low

$48.24

52 Week low$48.24

Analyst ratings

100%

of 10 ratings

Buy

100%

Hold

Sell

Vaxcyte

Why Robinhood?

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. Show more

PCVX Key Statistics

Analyst ratings

100%

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology.